Skip to main content
Clinical Trials/NCT05230485
NCT05230485
Unknown
Not Applicable

Optimal High CPAP Pressures in Preterm Neonates Post-extubation: A Prospective Randomized Crossover Trial

McMaster Children's Hospital1 site in 1 country26 target enrollmentFebruary 15, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
McMaster Children's Hospital
Enrollment
26
Locations
1
Primary Endpoint
Peak Edi
Last Updated
4 years ago

Overview

Brief Summary

Use of continuous positive airway pressure (CPAP) in preterm neonates has traditionally been limited to between 5-8 cmH2O. In recent years, use of CPAP pressures ≥9 cmH2O is becoming more common in neonates with evolving chronic lung disease, in lieu of other non-invasive modes or invasive mechanical ventilation. A particular knowledge gap in the current literature is the choice of the level of pressure level when using High CPAP as a post-extubation support mode. In this study, we will comparatively evaluate the short-term impact of two different high CPAP pressures when used as a post-extubation support mode in preterm neonates.

Detailed Description

Background: Use of continuous positive airway pressure (CPAP) in preterm neonates has traditionally been limited to between 5-8 cmH2O. In recent years, use of CPAP pressures ≥9 cmH2O is becoming more common in neonates with evolving chronic lung disease, in lieu of other non-invasive modes or invasive mechanical ventilation. However, there are limited data on the effectiveness and safety of this mode. A particular knowledge gap in the current literature is the choice of the level of pressure level when using High CPAP as a post-extubation support mode. While it could be argued that the initial High CPAP pressure post-extubation should be somewhat higher than the pre-extubation mean airway pressure (Paw), there remain concerns of potential complications as well as uncertainty around degree of leak and resulting effectiveness. On the other hand, a suboptimal post-extubation High CPAP level may lead to atelectasis and contribute towards extubation failure, potentially prolonging invasive ventilation and associated risks. As such, research towards identification of the optimal High CPAP level post-extubation from high invasive ventilation pressures is warranted. Objective: To comparatively evaluate the short-term impact of two different high CPAP pressures when used as a post-extubation support mode in preterm neonates. Hypothesis: We hypothesize that babies extubated from invasive mechanical ventilation with a mean Paw between 9-15 cmH2O will demonstrate better physiological and clinical parameters when using High CPAP+2 cmH2O vs equivalent CPAP levels. Methods: Design - This will be a prospective, single-centre, randomized cross-over study.

Registry
clinicaltrials.gov
Start Date
February 15, 2022
End Date
February 15, 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amit Mukerji

Associate Professor

McMaster Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Gestational age \<29 weeks; chronological age \>7 days; post-menstrual age \<37 weeks; extubation from invasive ventilation with measured mean airway pressure 9-15 cmH2O

Exclusion Criteria

  • Any congenital or genetic/chromosomal abnormality

Outcomes

Primary Outcomes

Peak Edi

Time Frame: 60 min following each CPAP level - assessed over 10 min

The peak electrical diaphragmatic activity - a surrogate for work of breathing to generate tidal volume

Secondary Outcomes

  • Minimum EDi(60 min following each CPAP level - assessed over 10 min)
  • Regional cerebral perfusion(60 min following each CPAP level - assessed over 10 min)
  • Pressure level - Ventilator(60 min following each CPAP level - assessed over 10 min)
  • Pressure level - Interface(60 min following each CPAP level - assessed over 10 min)
  • Work of breathing score(Over entire duration (70 min) at each CPAP level, assessed every 10 min)
  • Heart Rate(Over entire duration (70 min) at each CPAP level, assessed every 10 min)
  • Respiratory Rate(Over entire duration (70 min) at each CPAP level, assessed every 10 min)
  • Transcutaneous CO2 level(Over entire duration (70 min) at each CPAP level, assessed every 10 min)
  • FiO2 level(Over entire duration (70 min) at each CPAP level, assessed every 10 min)
  • Number of bradycardic episodes <80 bpm(Over entire duration (70 min) at each CPAP level)
  • Proportion of duration with SpO2 <90%(Over entire duration (70 min) at each CPAP level)

Study Sites (1)

Loading locations...

Similar Trials